サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1206649

医薬品分析試験アウトソーシング市場：タイプ別（API、添加物、最終製品）、サービス別、エンドユーザー別、地域別、2023-2028年

Pharmaceutical Analytical Testing Outsourcing Market by Type (Active Pharmaceutical Ingredients, Additives, Finished Products), Service, End User, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医薬品分析試験アウトソーシング市場：タイプ別（API、添加物、最終製品）、サービス別、エンドユーザー別、地域別、2023-2028年
出版日: 2023年01月31日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品分析試験アウトソーシングの世界市場規模は、2022年に79億米ドルに達しました。今後、IMARCグループは、2023年から2028年の間に7.74%の成長率（CAGR）を示し、2028年までに122億米ドルに達すると予測しています。

医薬品分析試験のアウトソーシングは、製薬業界において、業務の一部を外部に委託することで社内生産コストを最小化するために利用される試験活動です。医薬品分析試験アウトソーシングは、医薬品開発業務受託機関の延長として、自社での分析開発・試験の大部分を代替するようになっています。医薬品や治療法の開発プロセスの中で、医薬品試験は製品の初期段階から製品化まで重要な役割を担っています。医薬品試験には、化学物質の構造の決定、混合物の精製、医薬品有効成分（API）の合成と特性評価が含まれます。この取り組みには通常、製剤開発と初期段階の製造が含まれ、化合物の活動をスピードアップさせます。

医薬品分析試験アウトソーシングの市場動向

  • この市場は、製薬会社、医薬品開発業務受託機関、バイオテクノロジー企業におけるアウトソーシングの採用が増加していることが主な要因となっています。これは、さまざまな規制当局別医薬品開発のエンドツーエンドプロセスに関する分析情報への要求が高まっていることに起因していると思われます。さらに、製品ライフサイクルの短縮に重点を置いた継続的な技術の進歩により、新製品の開発が急速に進んでおり、これが市場に刺激を与えています。製品の安全性と品質に対するニーズの高まり、in vivoおよびin vitro試験に対する規制の変化、オーダーメイド医療の重視も、市場にプラスの影響を与えています。配合剤、バイオシミラー、その他の革新的な医薬品の開発により、特定のタイプの検査や特殊製品の製造が導入されていることも、さらに市場を活性化させています。その他、製薬業界における数々のイノベーション、アウトソーシングによる価格メリット、持続可能な医薬品開発のために行われる大規模な研究開発、各国政府による有利なイニシアティブ、臨床試験登録数の増加などが、市場に貢献しています。

主要市場のセグメンテーション

  • IMARC Groupは、世界の医薬品分析試験アウトソーシング市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を掲載しています。当レポートでは、市場をタイプ、サービス、エンドユーザーに基づいて分類しています。

タイプ別の内訳

  • 医薬品有効成分（API）
  • 添加物
  • 最終製品

サービス別内訳

  • バイオ分析試験
  • クリニカル
  • 非臨床試験
  • メソッド開発およびバリデーション
  • 抽出・浸出性
  • 不純物メソッド
  • 技術コンサルティング
  • その他
  • 安定性試験
  • 医薬品原料
  • 安定性指示法バリデーション
  • 加速安定性試験
  • 光安定性試験
  • その他
  • その他

エンドユーザー別内訳

  • 製薬会社
  • バイオ製薬会社
  • 研究開発受託機関

地域別の内訳

  • 北米
  • 米国
  • カナダ
  • アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
  • 中東とアフリカ

本レポートで回答した主な質問

  • 医薬品分析試験アウトソーシングの世界市場はこれまでどのように推移してきたか、また今後どのように推移していくか？
  • COVID-19は世界の医薬品分析試験アウトソーシング市場にどのような影響を及ぼしたか？
  • 主要な地域市場は？
  • タイプに基づく市場の内訳は？
  • サービス別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々なステージとは？
  • 業界における主要な促進要因と課題は何か？
  • 医薬品分析試験アウトソーシングの世界市場の構造、主要プレイヤーはどこか？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な業界動向

第5章 医薬品分析試験アウトソーシングの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 タイプ別市場内訳

  • 医薬品有効成分（API）
    • 市場動向
    • 市場予測
  • 添加物
    • 市場動向
    • 市場展望
  • 最終製品
    • 市場動向
    • 市場展望

第7章 サービス別市場内訳

  • バイオアナリティックテスティング
    • 市場動向
    • 主要企業
      • クリニカル
      • 非臨床
    • 市場予測
  • メソッド開発・バリデーション
    • 市場動向
    • キープレイヤー
      • 抽出・浸出可能な
      • 不純物メソッド
      • 技術コンサルティング
      • その他
    • 市場予測
  • 安定性試験
    • 市場動向
    • キープレイヤー
      • 医薬品の物質
      • 安定性指示法バリデーション
      • 加速安定性試験
      • 光安定性試験
      • その他
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 エンドユーザー別市場内訳

  • 製薬会社
    • 市場動向
    • 市場予測
  • バイオ製薬企業
    • 市場動向
    • 市場予測
  • 受託研究機関
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場展望
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場展望
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場展望
    • 韓国市場
      • 市場動向
      • 市場展望
    • オーストラリア
      • 市場動向
      • 市場展望
    • インドネシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場展望
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場展望
    • スペイン
      • 市場動向
      • 市場展望
    • ロシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場展望
    • メキシコ
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競争情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Ajinomoto Bio-Pharma Services（Ajinomoto Co. Inc.）
    • Alcami Corporation Inc.
    • Boston Analytical Inc.
    • Catalent Inc.
    • Charles River Laboratories International Inc.
    • Eurofins Scientific SE
    • Intertek Group plc
    • Laboratory Corporation of America Holdings
    • Pace Analytical Services LLC
    • SGS S.A.
    • Thermo Fisher Scientific Inc.
    • West Pharmaceutical Services Inc.
    • WuXi AppTec Inc.

本レポートに掲載されている企業名は一部であり、全企業名は本レポートに掲載されています。

図表

List of Figures

  • Figure 1: Global: Pharmaceutical Analytical Testing Outsourcing Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Service (in %), 2022
  • Figure 6: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Pharmaceutical Analytical Testing Outsourcing (Active Pharmaceutical Ingredients (API)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Pharmaceutical Analytical Testing Outsourcing (Active Pharmaceutical Ingredients (API)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Pharmaceutical Analytical Testing Outsourcing (Additives) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Pharmaceutical Analytical Testing Outsourcing (Additives) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Pharmaceutical Analytical Testing Outsourcing (Finished Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Pharmaceutical Analytical Testing Outsourcing (Finished Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Pharmaceutical Analytical Testing Outsourcing (Bioanalytical Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Pharmaceutical Analytical Testing Outsourcing (Bioanalytical Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Pharmaceutical Analytical Testing Outsourcing (Method Development and Validation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Pharmaceutical Analytical Testing Outsourcing (Method Development and Validation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Pharmaceutical Analytical Testing Outsourcing (Stability Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Pharmaceutical Analytical Testing Outsourcing (Stability Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Pharmaceutical Analytical Testing Outsourcing (Other Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Pharmaceutical Analytical Testing Outsourcing (Other Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Pharmaceutical Analytical Testing Outsourcing (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Pharmaceutical Analytical Testing Outsourcing (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Pharmaceutical Analytical Testing Outsourcing (Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Pharmaceutical Analytical Testing Outsourcing (Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Pharmaceutical Analytical Testing Outsourcing (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Pharmaceutical Analytical Testing Outsourcing (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Pharmaceutical Analytical Testing Outsourcing Industry: SWOT Analysis
  • Figure 78: Global: Pharmaceutical Analytical Testing Outsourcing Industry: Value Chain Analysis
  • Figure 79: Global: Pharmaceutical Analytical Testing Outsourcing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Analytical Testing Outsourcing Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by Service (in Million US$), 2023-2028
  • Table 4: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Pharmaceutical Analytical Testing Outsourcing Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Analytical Testing Outsourcing Market: Key Players
目次
Product Code: SR1323A121_Report

The global pharmaceutical analytical testing outsourcing market size reached US$ 7.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2028, exhibiting a growth rate (CAGR) of 7.74% during 2023-2028.

Pharmaceutical analytical testing outsourcing is a testing activity used in the pharmaceutical industry to minimize in-house production costs by outsourcing parts of the work to a third party. As an extension of contract research organizations, pharmaceutical analytical testing outsourcing services have begun replacing a significant portion of in-house analytical development and testing. As part of the development process for drugs and therapies, pharmaceutical testing plays a vital role from the beginning through the commercialization of the product. It entails determining the structures of chemicals, purifying a mixture of substances, and synthesizing and characterizing active medicinal ingredients (APIs). Formulation development and early-phase manufacturing are usually involved in this initiative to speed up compound activities.

Pharmaceutical Analytical Testing Outsourcing Market Trends:

  • The market is majorly driven by the increasing adoption of outsourcing practices in pharmaceutical companies, contract research organizations, and biotech companies. This can be attributed to the escalating demand for analytical information on the end-to-end process of drug development by various regulatory agencies. Additionally, continual technological advancements with an enhanced focus on shortening the product lifecycle have resulted in the rapid development of new products, which is providing an impetus to the market. The rising need for product safety and quality, changing regulations for in vivo and in vitro tests, and an augmented emphasis on customized care is also impacting the market positively. The development of combination products, biosimilar, and other innovative medicines leading to the introduction of specific types of tests and specialty product manufacturing are further fueling the market. Some of the other factors contributing to the market include numerous innovations in the pharmaceutical industry, the pricing benefits of outsourcing, extensive research and development (R&D) conducted to develop sustainable drugs, favorable initiatives by the governments of several countries, and the growing number of clinical trial registrations.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical analytical testing outsourcing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, service and end user.

Breakup by Type:

  • Active Pharmaceutical Ingredients (API)
  • Additives
  • Finished Products

Breakup by Service:

  • Bioanalytical Testing
  • Clinical
  • Non-Clinical
  • Method Development and Validation
  • Extractable and Leachable
  • Impurity Method
  • Technical Consulting
  • Others
  • Stability Testing
  • Drug Substance
  • Stability Indicating Method Validation
  • Accelerated Stability Testing
  • Photostability Testing
  • Others
  • Others

Breakup by End User:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Research Organizations

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Bio-Pharma Services (Ajinomoto Co. Inc.), Alcami Corporation Inc., Boston Analytical Inc., Catalent Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Intertek Group plc, Laboratory Corporation of America Holdings, Pace Analytical Services LLC, SGS S.A., Thermo Fisher Scientific Inc., West Pharmaceutical Services Inc. and WuXi AppTec Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global pharmaceutical analytical testing outsourcing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical analytical testing outsourcing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the service?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical analytical testing outsourcing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Analytical Testing Outsourcing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Active Pharmaceutical Ingredients (API)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Additives
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Finished Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Service

  • 7.1 Bioanalytical Testing
    • 7.1.1 Market Trends
    • 7.1.2 Key Players
      • 7.1.2.1 Clinical
      • 7.1.2.2 Non-Clinical
    • 7.1.3 Market Forecast
  • 7.2 Method Development and Validation
    • 7.2.1 Market Trends
    • 7.2.2 Key Players
      • 7.2.2.1 Extractable and Leachable
      • 7.2.2.2 Impurity Method
      • 7.2.2.3 Technical Consulting
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast
  • 7.3 Stability Testing
    • 7.3.1 Market Trends
    • 7.3.2 Key Players
      • 7.3.2.1 Drug Substance
      • 7.3.2.2 Stability Indicating Method Validation
      • 7.3.2.3 Accelerated Stability Testing
      • 7.3.2.4 Photostability Testing
      • 7.3.2.5 Others
    • 7.3.3 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Biopharmaceutical Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ajinomoto Bio-Pharma Services (Ajinomoto Co. Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Alcami Corporation Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Boston Analytical Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Catalent Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Charles River Laboratories International Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Eurofins Scientific SE
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Intertek Group plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Laboratory Corporation of America Holdings
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pace Analytical Services LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 SGS S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 West Pharmaceutical Services Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 WuXi AppTec Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.